The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.
AUM ( in Cr.)
portfolio price to book value
inception date (regular plan)
expense ratio (regular plan) %
Copyright © 2017 Vedant Asset. All Right Reserved.
Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past
performance is not an indicator of future returns. ARN-104974